The Dose
Archives
Search...
Subscribe
Wegovy HD approved, GLP-1 discontinuation risk quantified, BPC-157 fraud confirmed
March 26, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era Thursday, March 26, 2026 COMPOUND WATCH Wegovy HD (semaglutide...
Orforglipron beats oral sema on every endpoint; BPC-157 Phase 2 recruiting; Cleveland Clinic says the weight-regain narrative is wrong
March 25, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era. Wednesday, March 25, 2026 COMPOUND WATCH Orforglipron (Lilly,...
BPC-157 hits Phase 2; stopping GLP-1s = 22% higher CV risk; India's $1.59 semaglutide pill
March 24, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era. Tuesday, March 24, 2026 COMPOUND WATCH BPC-157 [Animal →...
Retatrutide Phase 3: 16.8% in T2D — but tirzepatide hits 21-22% in obesity. Here's the real comparison.
March 23, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era. Monday, March 23, 2026 COMPOUND WATCH Retatrutide (LY3437943)...
GenoGenix ER visits, 30 warning letters, reta at 22% approval odds — and the VA study nobody's talking about
March 19, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era. Thursday, March 19, 2026 COMPOUND WATCH Retatrutide (Reta)...
Tirzepatide + B12 unknown impurity; Wegovy vision 5x; Samsung long-acting sema deal
March 16, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era. Monday, March 16, 2026 COMPOUND WATCH Tirzepatide (compounded...
Lilly's Impurity Bomb, BPC-157 Phase 2 Recruiting, RFK Day 13: Still Nothing
March 12, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era. Thursday, March 12, 2026 COMPOUND WATCH Compounded...
BPC-157 Gets Its First Human Trial — And Novo Just Blinked
March 11, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era. Wednesday, March 11, 2026 COMPOUND WATCH BPC-157 [Animal →...
BPC-157's first human trial, Peptide Sciences folds, and why male GLP-1 results lag
March 10, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era Tuesday, March 10, 2026 COMPOUND WATCH BPC-157 [Phase 2 —...
Hims Folds, Orforglipron Can't Be Compounded, India Generics Land March 21
March 9, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era Monday, March 9, 2026 COMPOUND WATCH Orforglipron (Lilly, oral...
Petrelintide 10.7% vs. the oral pill field; GenoGenix ER visits; BPC-157 Phase 2 now recruiting
March 6, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era Friday, March 6, 2026 COMPOUND WATCH Petrelintide (amylin...
Orforglipron Q2 approval, 30 FDA warning letters, and the peptide list that still isn't law
March 5, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era Thursday, March 5, 2026 COMPOUND WATCH Orforglipron [Phase 3]...
BPC-157 Gets Its First Human RCT — What It Tests (And What It Won't Answer)
March 4, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era. Wednesday, March 4, 2026 | Issue #3 Data status: Third...
BPC-157 has one human trial. It tests one thing. Here's what that means for your stack.
March 3, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era. Tuesday, March 03, 2026 | Issue #2 Data provenance note —...
BPC-157 just entered Phase 2. Here's what that actually means — and what it won't tell you yet.
March 2, 2026
THE DOSE The peptide market decoded — science, signal, and BS detection for the biohacking era. Monday, March 02, 2026 | Issue #001 Data quality notice —...